IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PIZZI, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.630
EU - Europa 8.086
AS - Asia 6.482
SA - Sud America 1.087
Continente sconosciuto - Info sul continente non disponibili 605
AF - Africa 156
OC - Oceania 19
AN - Antartide 1
Totale 30.066
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.222
PL - Polonia 3.268
CN - Cina 2.146
SG - Singapore 2.027
UA - Ucraina 1.059
IT - Italia 996
BR - Brasile 880
DE - Germania 785
HK - Hong Kong 639
VN - Vietnam 508
FI - Finlandia 422
GB - Regno Unito 406
FR - Francia 364
IN - India 332
RU - Federazione Russa 269
TR - Turchia 210
BD - Bangladesh 197
CA - Canada 194
IE - Irlanda 183
ID - Indonesia 74
MX - Messico 63
AR - Argentina 62
NL - Olanda 59
JP - Giappone 55
SE - Svezia 50
IQ - Iraq 49
BE - Belgio 44
ZA - Sudafrica 44
ES - Italia 43
KR - Corea 35
CR - Costa Rica 33
CZ - Repubblica Ceca 31
CO - Colombia 30
EC - Ecuador 30
IL - Israele 30
PK - Pakistan 30
AT - Austria 27
UZ - Uzbekistan 23
VE - Venezuela 23
CL - Cile 21
MA - Marocco 19
JM - Giamaica 18
KE - Kenya 18
IR - Iran 17
NI - Nicaragua 17
AU - Australia 16
EU - Europa 16
NG - Nigeria 15
HN - Honduras 14
TT - Trinidad e Tobago 14
SC - Seychelles 13
SV - El Salvador 13
PE - Perù 12
PY - Paraguay 12
SA - Arabia Saudita 12
AE - Emirati Arabi Uniti 11
JO - Giordania 11
GP - Guadalupe 10
GT - Guatemala 10
LT - Lituania 10
PH - Filippine 10
TN - Tunisia 10
AZ - Azerbaigian 9
CW - ???statistics.table.value.countryCode.CW??? 9
UY - Uruguay 9
CH - Svizzera 8
EE - Estonia 8
ET - Etiopia 8
OM - Oman 8
BO - Bolivia 7
DZ - Algeria 7
PR - Porto Rico 7
AL - Albania 6
EG - Egitto 6
KZ - Kazakistan 6
MU - Mauritius 6
RO - Romania 6
LV - Lettonia 5
MY - Malesia 5
NP - Nepal 5
BG - Bulgaria 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
HU - Ungheria 4
LK - Sri Lanka 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TW - Taiwan 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
GE - Georgia 3
HR - Croazia 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
PA - Panama 3
PT - Portogallo 3
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
CY - Cipro 2
Totale 29.450
Salva come PNG Salva come JPEG
Città #
Warsaw 3.258
Ashburn 1.275
Singapore 1.060
Fairfield 1.040
Woodbridge 813
Jacksonville 734
Hong Kong 633
San Jose 633
Houston 628
Council Bluffs 500
Ann Arbor 493
Chandler 474
Beijing 446
Cambridge 441
Seattle 417
Wilmington 389
The Dalles 343
New York 326
Princeton 319
Nanjing 298
Brescia 287
Los Angeles 277
Helsinki 256
Dallas 212
Dearborn 206
Dublin 182
Lauterbourg 171
Istanbul 167
Columbus 149
Dong Ket 126
Ho Chi Minh City 117
Milan 114
Munich 114
Chicago 110
Buffalo 109
Des Moines 103
Santa Clara 99
São Paulo 96
San Francisco 93
Nanchang 90
Pune 84
Hanoi 81
Shenyang 80
Moscow 74
Shanghai 72
Hebei 71
Jinan 69
Tianjin 69
Redondo Beach 68
Lancaster 66
Changsha 62
Phoenix 60
London 59
Orem 59
Toronto 55
San Diego 54
Montreal 53
Rome 50
Jakarta 49
Brooklyn 41
Brussels 41
Denver 39
Chennai 36
Tokyo 35
Turku 35
Atlanta 34
Guangzhou 33
Kunming 32
North Bergen 32
Jiaxing 31
Hangzhou 30
Salt Lake City 30
Ningbo 29
Zhengzhou 29
Amsterdam 27
Nuremberg 27
San José 27
Brasília 26
Rio de Janeiro 26
Manchester 24
Boardman 23
Frankfurt am Main 23
Verona 23
Baghdad 22
Lanzhou 22
Manassas 22
Stockholm 22
Taizhou 22
Tashkent 22
Johannesburg 21
Tampa 21
Boston 20
Mexico City 20
Norwalk 20
Brno 19
Belo Horizonte 18
Dhaka 18
Mumbai 18
Orange 18
Paris 18
Totale 19.909
Salva come PNG Salva come JPEG
Nome #
Neuroprotective and Anti-Apoptotic Effects of CSP-1103 in Primary Cortical Neurons Exposed to Oxygen and Glucose Deprivation 387
CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid 385
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease 371
Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation 362
Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window. 347
PEA and luteolin synergistically reduce mast cell-mediated toxicity and elicit neuroprotection in cell-based models of brain ischemia 346
1B/(-)IRE DMT1 Expression during Brain Ischemia Contributes to Cell Death Mediated by NF-κB/RelA Acetylation at Lys310 334
Glutamatergic neurons induce expression of functional glutamatergic synapses in primary myotubes. 333
Priming of cultured neurons with sabeluzole results in long-lasting inhibition of neurotoxin-induced tau expression and cell death. 331
Glutamatergic Reinnervation and Assembly of Glutamatergic Synapses in Adult Rat Skeletal Muscle Occurs at Cholinergic Endplates 329
Glutamatergic reinnervation through peripheral nerve graft dictates assembly of glutamatergic synapses at rat skeletal muscle 328
A Polyphenol-Enriched Supplement Exerts Potent Epigenetic-Protective Activity in a Cell-Based Model of Brain Ischemia 318
NF-κB and epigenetic mechanisms as integrative regulators of brain resilience to anoxic stress. 317
Dopamine transporter/α-synuclein complexes are altered in the post mortem caudate putamen of Parkinson’s disease: An in situ proximity ligation assay study 310
NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases 304
1,2,4-Triazine derivatives as agents for the prevention of AGE-RAGE-mediated inflammatory cascade in THP-1 monocytes: An approach to prevent inflammation-induced late diabetic complications 300
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice. 294
Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model 287
Mild inflammatory profile without gliosis in the c-rel deficient mouse modeling a late-onset parkinsonism 279
Synergistic association of valproate and resveratrol reduces brain injury in ischemic stroke 276
The End Is the Beginning: Parkinson's Disease in the Light of Brain Imaging 273
The Contribution of -Synuclein Spreading to Parkinson’s Disease Synaptopathy 271
Pharmacological targeting of the beta-amyloid precursor protein intracellular domain 251
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate 241
NUOVO IMPIEGO TERAPEUTICO PREVENTIVO DELLA SUBUNITA' C-REL DELLA PROTEINA NF-KAPPAB E NUOVO IMPIEGO DI UN ANIMALE TRASGENICO NON UMANO CHE PORTA LA DELEZIONE DEL GENE C-REL (C-REL-/-) 232
Chapter 24 NF-KappaB Dimers in the Regulation of Neuronal Survival 222
NF-kappaB p50/RelA and c-Rel-containing dimers: opposite regulators of neuron vulnerability to ischaemia. 221
NF-κB/c-Rel deficiency causes Parkinson's disease-like prodromal symptoms and progressive pathology in mice 221
The Role of Mast Cells in Stroke 221
Mitochondria and alpha-synuclein: Friends or foes in the pathogenesis of Parkinson's disease? 220
The gamma-Secretase Modulator CHF5074 Reduces the Accumulation of Native Hyperphosphorylated Tau in a Transgenic Mouse Model of Alzheimer's Disease 218
The gamma-secretase modulator CHF5074 elicits neuroprotection and increases histone acetylation in primary cortical neurons exposed to oxygen glucose deprivation 216
Bim and Noxa are candidates to mediate the deleterious effect of the NF-kappa B subunit RelA in cerebral ischemia. 213
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 213
Post-ischemic brain damage: NF-kappaB dimer heterogeneity as a molecular determinant of neuron vulnerability 212
Raman Probes for in Situ Molecular Analyses of Peripheral Nerve Myelination 212
A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release. 208
c-Rel deficient mice, a mouse model of "spreading" PD-like pathology. 208
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 207
Activation of dopamine D2 receptors linked to voltage-sensitive potassium channels reduces forskolin-induced cyclic AMP formation in rat pituitary cells. 202
Targeting IKK2 by pharmacological inhibitor AS602868 prevents excitotoxic injury to neurons and oligodendrocytes. 201
Spinal cord mGlu1a receptors - Possible target for amyotrophic lateral sclerosis therapy 198
Antisense strategy unravels tau proteins as molecular risk factors for glutamate-induced neurodegeneration. 198
Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line 194
A Tau antisense oligonucleotide decreases neurone sensitivity to excitotoxic injury. 190
Risk and protective factors associated with mental health status in an Italian sample of students during the fourth wave of COVID-19 pandemic 186
Differential pattern of expression of G proteins in nucleus striatum from 6-hydroxydopamine lesioned rats. 186
α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons 185
Synergistic association of valproate and resveratrol reduces brain injury in ischemic stroke. 183
Activation of multiple metabotropic glutamate receptor subtypes prevents NMDA-induced excitotoxicity in rat hippocampal slices. 182
EXACERBATED AGE-DEPENDENT LOSS OF NIGRAL DOPAMINERGIC NEURONS IN NF-KAPPAB C-REL -/- MICE 180
c-Rel deficient mice, a mouse model of “spreading” PD-like pathology 178
Electrophysiological and metabolic effects of CHF5074 in the hippocampus: protection against in vitro ischemia. 177
Involvement of Synapsin III in the onset of Alpha-synuclein pathology in Parkinson’s Disease 176
Mitochondrial Dysfunction and Alpha-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First? 174
Synapsin III alterations in Parkinson's disease 174
Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells. 174
NF-κB unbalance and dysfunction in acute and age-related neurodegenerative disease 173
Synapsin III and Alpha-Synuclein cooperation in the onset of synaptic pathology in Parkinson’s Disease 171
AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons of Synapsin III knockout mice reveals novel molecular features involved in Parkinson's disease pathology. 170
N-methyl-D-aspartate neurotoxicity in hippocampal slices: protection by aniracetam. 169
Acetylation of NF-kappaB p50/RelA and histones in the epigenetic regulation of pro-apoptotic transcription: a neuroprotective target in brain ischemia 167
Cellular mechanisms for neurotensin receptor-mediated release of prolactin. 167
Degenerazione età –dipendente dei neuroni dopaminergici della sostanza nera nei topi NF-kappaB cRel 166
A bioinformatics analysis of memory consolidation reveals involvement of the transcription factor c-rel. 164
CHF5074, a novel gamma-secretase modulator, attenuates brain beta-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease. 163
DIVALENT METAL TRANSPORTER 1-DEPENDENT ISCHEMIC NEURODEGENERATION: STRATEGIES TO KNOCKDOWN FERROUS IRON UPTAKE 161
Cortical neurons induce the expression of glutamate receptors in primary myotubes 160
SYNERGIC ROLE OF RESVERATROL AND HDACi MS-275 IN NEUROPROTECTION 159
Inhibition of glutamate-induced neurotoxicity by a tau antisense oligonucleotide in primary culture of rat cerebellar granule cells 159
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 158
Inhibition of IκBα phosphorylation prevents glutamate-induced NF-κB activation and neuronal cell death 157
A soluble interleukin-6 (IL6) recepetor/IL6 fusion protein enhances the in vitro differentiation of purified rat oligodendroglial lineage cells 156
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of Parkinson’s disease and dementia with Lewy bodies, 156
Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol. 155
Dopamine D2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices. 155
Tolerance to hypoactivity and sensitization to hyperactivity after chronic treatment with a presynaptic dose of lisuride in rats 155
Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells. 154
Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells. 154
The interplay among nonsuicidal self-injury, depression, loneliness, resilience, and family relationships in youth: A path analysis 152
Opposing regulation of amyloid precursor protein by ionotropic and metabotropic glutamate receptors. 151
An in vitro method of diagnosing Parkinson's disease 151
Synapsin III Alteration in Parkinson's disease 151
Synapsin III Alteration in Parkinson's disease 151
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease 150
Alpha-Synuclein in the Regulation of Brain Endothelial and Perivascular Cells: Gaps and Future Perspectives 150
An updated reappraisal of synapsins: structure, function and role in neurological and psychiatric disorders 150
Pharmacological basis for dopamine D-2 receptor diversity 149
Differential expression of fetal and mature tau isoforms in primary cultures of rat cerebellar granule cells during differentiation in vitro 149
Various Ca2+ entry blockers prevent glutamate-induced neurotoxicity. 148
Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation 147
From preclinical stroke models to humans: Polyphenols in the prevention and treatment of stroke 146
Properties of benzodiazepine binding sites in peripheral blood lymphocytes 145
Repeated administration of (−) sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions 145
NF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production 144
Blockade of the tumor necrosis factor-related apoptosis inducing ligand death receptor DR5 prevents beta-amyloid neurotoxicity. 143
Peripheral and central mechanisms of action of serotoninergic anorectic drugs. 143
Lack of vasoactive intestinal peptide-releasing property in prolactin cells from ovariectomized rats: contribution of post-transductional impairments 143
NF-kappaB dimer heterogeneity: a molecular determinant of neuron vulnerability in post ischemic brain damage 138
The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury. 138
Totale 20.789
Salva come PNG Salva come JPEG
Categoria #
all - tutte 126.999
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.999
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022941 0 0 0 0 25 64 87 77 70 181 129 308
2022/20231.311 187 34 56 102 134 329 3 132 192 27 58 57
2023/20241.384 92 34 120 82 68 325 55 66 276 31 33 202
2024/20253.480 24 44 34 408 344 208 335 122 513 164 864 420
2025/20267.405 707 896 551 1.048 745 566 1.068 331 435 576 334 148
2026/20272.519 435 322 582 970 210 0 0 0 0 0 0 0
Totale 30.066